Category

Daily Briefs

Daily Brief Industrials: DS Dansuk, Enav SpA, Norcros PLC, NOW Inc and more

By | Daily Briefs, Industrials

In today’s briefing:

  • DS Dansuk: Block Deal Sale by Stonebridge Capital
  • Enav Spa (ENAV IM) – Tuesday, Feb 27, 2024
  • Norcros – Vast opportunity and new targets revealed
  • DNOW, Inc. – FY24 Free Cash Flow Outlook Lifted


DS Dansuk: Block Deal Sale by Stonebridge Capital

By Douglas Kim

  • After the market close on 28 May, it was announced that Stonebridge Capital plans to conduct a block deal sale of a portion of its stake in DS Dansuk.
  • This deal involves 210,000 to 290,000 shares of DS Dansuk. The block deal price range is from 99,800 won to 101,400 won, which represents 7.06% to 8.52% discount.
  • After this second block deal, there will be further overhang concerns about additional sales of DS Dansuk by Stonebridge Capital in the coming months. 

Enav Spa (ENAV IM) – Tuesday, Feb 27, 2024

By Value Investors Club

  • ENAV’s stock trades at a lower multiple compared to peers in the European airport concession industry
  • Shareholder activism could potentially influence board decisions despite majority ownership by the Italian government
  • ENAV’s cash flow is expected to improve, offering a potential 15% free cash flow yield by 2025 and presents minimal downside risk with significant upside potential if it trades closer to historical valuation multiples

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Norcros – Vast opportunity and new targets revealed

By Edison Investment Research

Norcros is the UK’s leading design-led sustainable kitchen and bathroom products group. Its compelling investment case was highlighted at its May 2024 capital markets day (CMD), where its unique, asset-light, design-led model was clearly illustrated. The CMD also indicated the enormous scale of the opportunity that is available in terms of entering adjacent unaddressed markets in the UK and South Africa, as well as the potential presented by other attractive geographies. Furthermore, revised medium-term targets were introduced that should further excite investors. Our profit forecasts are unchanged, but we have raised our valuation from 246p to 251p as we have rolled forward our P/E valuation and increased our FY25 dividend estimate.


DNOW, Inc. – FY24 Free Cash Flow Outlook Lifted

By Water Tower Research

  • The 1Q24 Whitco Supply acquisition diversified DNOW’s customer base and added new revenue opportunities in the midstream markets.
  • Management now expects FY24 revenue to increase in the mid- to high single digits range from FY23 and for adjusted EBITDA margin to be in line with FY23.
  • Management lifted its FY24 free cash flow outlook to ~$200 million from ~$150 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Akeso Biopharma Inc, JTEC Corp/Osaka, Sichuan Kelun-Biotech Biopharm, Jiangxi Rimag Group, Abeona Therapeutics , Edesa Biotech , NeuroBo Pharmaceuticals , Essa Pharma and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Is Akeso’s Sell-Off a Long Waited Opportunity or a Long Overdue Correction?
  • JTEC Corp (3446) – Facing Some Challenges over Lead Times
  • Sichuan Kelun-Biotech Biopharm (6990.HK) – Current High Valuation Is Not Secure
  • Pre-IPO Jiangxi Rimag Group (PHIP Updates) – Some Points Worth the Attention
  • ABEO: BLA Resubmission in 2H24
  • EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo
  • NRBO: Preclinical Data on DA-1241 with Semaglutide to be Presented at EASL Congress 2024
  • EPIX: Updated Data from Phase 1 Trial of Masofaniten and Enzalutamide Expected in 2H24


Is Akeso’s Sell-Off a Long Waited Opportunity or a Long Overdue Correction?

By Eric Wen

  • Disputable Phase III result of Akeso’s (9926 HK) flagship pipeline Ivonescimab (AK112) caused Akeso’s share price to drop 28% in three days, reaching the bottom of a year-long trading range;
  • The fundamental difference of opinions is around Ivonescimab’s global prospects against (1) Merck’s Keytruda, (2) J&J’s Rybrevant, (3) Kelun’s SKB264 and domestic prospect against (4) Innovent’s IBI305;
  • Some answers are clear while others are now. What can provide answers are (1) SKB264‘s Phase III data, and to a lesser degree (2) AK112’s head-to-head trial against Keytruda.

JTEC Corp (3446) – Facing Some Challenges over Lead Times

By Astris Advisory Japan

  • Lengthening order lead times impacting revenue recognition – Q1-3 FY6/24 results were behind expectations in our view, with sales declining 27.6% YoY.
  • Whilst a negative optic, the reason stems from lengthening lead times for shipment, given customer demands for more high-end and exacting technical requirements for custom-made products requiring more time for delivery.
  • We believe this highlights the value-added technical expertise of the company and delays in revenue recognition. 

Sichuan Kelun-Biotech Biopharm (6990.HK) – Current High Valuation Is Not Secure

By Xinyao (Criss) Wang

  • The imagination space and good stories for Sichuan Kelun-Biotech Biopharm (6990 HK) at this stage mainly come from SKB264. The market has higher expectations for SKB264’s clinical data on NSCLC/TNBC. 
  • The better the clinical results of SKB264 +PD1/L1, the greater the negative impact on AK112’s future expectations/market space in NSCLC. ADC +PD-1 seems more “convincing” than the logic of BsAb.
  • This July, restricted shares of major shareholders will be lifted, which may lead to big share price fluctuation if they reduce their shareholdings. Investors need not rush to be long.

Pre-IPO Jiangxi Rimag Group (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Considering the dominant position of medical imaging centers in public hospitals and challenges from other players, future development space of Rimag would be squeezed,and even will soon encounter growth bottlenecks.
  • Although Rimag turned losses into profits, we still have doubts about its future profitability due to increasing costs and potential price decline.This business may fail to bring investors decent profits.
  • Rimag’s post-investment valuation after last round financing isn’t cheap.Given the uncertainty of future revenue growth prospects and the real market space, P/S of below 3 is a more comfortable range.

ABEO: BLA Resubmission in 2H24

By Zacks Small Cap Research

  • On May 15, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2024 and provided a business update.
  • The company is planning to resubmit the Biologics License Application (BLA) for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa (RDEB) in the second half of 2024 following the receipt of a Complete Response Letter (CRL) in April 2024.
  • The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data but did request additional CMC information.

EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo

By Zacks Small Cap Research

  • On May 10, 2024, Edesa Biotech, Inc. (EDSA) announced financial results for the second quarter of fiscal year 2024 that ended March 31, 2024 and provided a business update.
  • Edesa is planning to seek regulatory approval for a Phase 2 trial of its anti-CXCL10 mAb in patients with moderate-to-severe nonsegmental vitiligo.
  • For EB05, the company has expanded site selection activities for the Phase 3 study in acute respiratory distress syndrome (ARDS) caused by COVID-19 and has begun transitioning the day-to-day management of the trial to a new clinical research organization (CRO).

NRBO: Preclinical Data on DA-1241 with Semaglutide to be Presented at EASL Congress 2024

By Zacks Small Cap Research

  • On May 22, 2024, NeuroBo Pharmaceuticals, Inc. (NRBO) announced that preclinical data of DA-1241 in combination with semaglutide in mouse models of metabolic dysfunction-associated steatohepatitis (MASH) will be presented at the EASL Congress 2024 on Thursday, June 6, 2024.
  • Two abstracts will be presented: one using the GAN diet-induced obese and biopsy-confirmed mouse model of MASH and one using the CCl4 induced liver fibrosis model.
  • The company shared some of the results that showed an additive effect on different parameters of liver health in both models, with the posters being available following the presentations.

EPIX: Updated Data from Phase 1 Trial of Masofaniten and Enzalutamide Expected in 2H24

By Zacks Small Cap Research

  • On May 14, 2024, ESSA Pharma Inc. (EPIX) announced financial results for the second quarter of fiscal year 2024 that ended March 31, 2024 and provided a business update.
  • ESSA is currently studying its lead compound, masofaniten (EPI-7386), in two clinical trials: EPI-7386-CS-001 and EPI-7386-CS-010.
  • The -001 trial consists of Part A monotherapy treatment and Part B combination therapy of masofaniten plus abiraterone acetate/prednisone (Cohort 1 mHSPC or mCRPC) or with apalutamide following 12 weeks of monotherapy therapy (Cohort 2 nmCRPC).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: PNB Housing Finance Ltd, QV Equities Ltd, Banco De Sabadell SA, China Vanke , Deutsche Beteiligungs AG and more

By | Daily Briefs, Financials

In today’s briefing:

  • PNB Housing: Block Deal Trade Special Situations and Tactical Trade Strategy
  • QV Equities (QVE AU): 28th June Shareholder Vote
  • BBVA Files Hostile Offer: Conditions, Defences and Probabilities
  • Morning Views Asia: China Vanke
  • Deutsche Beteiligungs – Successful exits assist H124 performance


PNB Housing: Block Deal Trade Special Situations and Tactical Trade Strategy

By Nimish Maheshwari

  • Impending block deals which generally create supply over-hang on the stock leads to a negative impact on the stock. 
  • These block deals generally include selling promoters and big funds at a price discount to its current market price. 
  • Historically, such events suggest once the block deal is done; stock reacts positively creating a Special Situation Opportunity

QV Equities (QVE AU): 28th June Shareholder Vote

By David Blennerhassett

  • On the 12th March, Aussie-based investment plays QV Equities Ltd (QVE AU) and WAM Leaders Ltd (WLE AU)  entered into a Scheme
  • The current scrip terms are 0.739 new WAM shares per QVE share; OR A$0.989/share cash. Terms will be adjusted for updated pre-tax NTA/shares of both companies after the Scheme Meeting. 
  • The Scheme Booklet is now out, with a Scheme Meeting to be held on the 28th June. Expected implementation on the 15 July. The IE says fair & reasonable.

BBVA Files Hostile Offer: Conditions, Defences and Probabilities

By Jesus Rodriguez Aguilar

  • On 24 May, Banco Bilbao Vizcaya Argentari (BBVA SM) submitted the authorisation request for its all-stock offer for Banco De Sabadell SA (SAB SM). Closing expected to take 6-8 months.
  • Gross spread (CSP 27 May) is 7.6%, which This translates in a 52% implied probability of deal success. The fixed income market appears to share this view.
  • Nevertheless, from a long-only perspective, the risk/reward of Sabadell is interesting. The deal values Sabadell’s shares at €2.07 each, an implied equity value of €11,187 million, for a 0.92 P/TBV.

Morning Views Asia: China Vanke

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Deutsche Beteiligungs – Successful exits assist H124 performance

By Edison Investment Research

Deutsche Beteiligungs (DBAG) reported an NAV total return of 3% in H124 (to March 2024) following the first-time recognition of 2024 portfolio company budgets and 2024 consensus forecasts for peers in Q124. Its H124 return includes a net €19m negative effect from the incorporation of additional portfolio valuation factors. DBAG’s H124 performance was supported by the successful sale of in-tech at a healthy 3.2x multiple on invested capital (MOIC). DBAG also closed the initial investment in a 51% stake in ELF Capital. Its shares now trade at a c 22% discount to NAV.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: TSE Tokyo Price Index TOPIX, Rize , Virtuoso Optoelectronics, Watches of Switzerland, Deliveroo, Guess? Inc and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Increasing Profitability to Gain Support from Overseas Investors Is a Condition for Higher Valuation
  • Temasek co-leads $14m round of SG agritech firm Rize
  • Virtuoso Optoelectronics Ltd- Forensic Analysis
  • Watches Of Switzerland (WOSG LN) – Tuesday, Feb 27, 2024
  • Deliveroo (ROO) – Tuesday, Feb 27, 2024
  • GES: 1Q Preview: Building for the Future: Reiterate Buy, $37 PT


Increasing Profitability to Gain Support from Overseas Investors Is a Condition for Higher Valuation

By Aki Matsumoto

  • Even after the TSE’s request for a P/B increase, it is not possible to raise valuations simply on the expectation of a P/B increase without improving profitability.
  • Most companies have cash allocation challenges. Companies with higher profitability will accumulate even more cash on hand, so higher level of shareholder return will further positively impact ROE and ROA.
  • Some of the companies that have reduced valuations include those with relatively high ROE and ROA, so there are small-cap stocks with reduced valuations and increased investment opportunities.

Temasek co-leads $14m round of SG agritech firm Rize

By Tech in Asia

  • Rize, a Singapore-based agritech startup, has secured US$14 million in a series A funding round co-led by Breakthrough Energy Ventures, GenZero, Temasek, and Wavemaker Impact.
  • The company plans to use the funds to boost its presence in other markets like Indonesia and Vietnam.
  • It also aims to increase its team of agronomy experts to over 100. Rize’s platform gathers key agricultural information needed for sustainable farming.

Virtuoso Optoelectronics Ltd- Forensic Analysis

By Nitin Mangal

  • Virtuoso Optoelectronics (VOEPL IN)  is a contract manufacturer company engaged into production of ACs, Lightings and other equipments. The company is renowned for supplying ACs to Voltas.
  • The company has grown sharply over the last five years and has been engaging in constant capex. However, it does struggle in converting its earnings to cash.
  • Among the forensic checks, it nets off receivables and payables/advances, the exact nature of these line items cannot be commented upon. VOEPL also faces high cost of borrowings

Watches Of Switzerland (WOSG LN) – Tuesday, Feb 27, 2024

By Value Investors Club

  • WOS is a luxury watch and fine jewelry retailer, with a focus on selling Rolex and other luxury brands
  • Despite strong financial performance and earnings growth, the company’s stock price has dropped significantly
  • Market misunderstanding of the impact of Rolex’s acquisition of Bucherer has led to WOS being undervalued, presenting a buying opportunity for investors.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Deliveroo (ROO) – Tuesday, Feb 27, 2024

By Value Investors Club

  • Deliveroo has seen a 30% increase in its stock since last year, making it a compelling investment opportunity
  • The company’s focus on independent restaurants results in higher average order values and better unit economics
  • Deliveroo is well-positioned to achieve its 2026 targets, with potential M&A and index inclusion catalysts in the near future

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


GES: 1Q Preview: Building for the Future: Reiterate Buy, $37 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, $37 price target and projections for Guess?
  • with the company announcing 1QFY25 (April) results after the close on Thursday.
  • We believe 1Q, which included material upgrades in the domestic retail store base, the acquisition of contemporary leader rag & bone, continued European expansion and what we believe were cautious buys from the domestic wholesale segment, will set the stage for a strong back-half and FY26, but will result, beyond further share repurchases, in limited top and bottom line upside for 1Q.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Private Markets: EBITA-profitable Allies of Skin raises $20m for US expansion and more

By | Daily Briefs, Private Markets

In today’s briefing:

  • EBITA-profitable Allies of Skin raises $20m for US expansion
  • SeaTown leads US$40M funding of asset servicing firm Linnovate Partners | e27
  • Wavemaker leads $4m round of Staple
  • Elevarm Raises US$2.6M to Empower Indonesia’s Small-Holder Farmers | E27
  • Jejakin raises US$2.7M to help organisations achieve net zero targets | e27


EBITA-profitable Allies of Skin raises $20m for US expansion

By Tech in Asia

  • Singapore-based beauty brand Allies of Skin is set to expand into the US after raising a US$20 million funding round from Meaningful Partners.
  • This follows the company hitting positive EBITA in 2023, its founder Nicolas Travis told Tech in Asia.
  • Allies of Skin, founded in 2016, said the round is its first institutional raise, but it has received private investments in the past – including capital from Crazy Rich Asians star Henry Golding.

SeaTown leads US$40M funding of asset servicing firm Linnovate Partners | e27

By e27

  • Singapore-based Linnovate Partners, an asset servicing and fintech company for the alternative investment industry, has received a US$40 million funding commitment led by Temasek-owned SeaTown Private Capital Master Fund.
  • This capital infusion will enable Linnovate to scale operations and drive innovation.
  • Henry Lin, founder and CEO of Linnovate Partners, said: “This investment will be instrumental in accelerating our growth trajectory, providing us with the necessary resources to enhance our service offering, and continue delivering cutting-edge solutions to our clients and the industry itself.”

Wavemaker leads $4m round of Staple

By Tech in Asia

  • Companies handle anywhere from 1,000 to 100,000 documents in various formats on a monthly basis, and they usually rely on manual processes due to the unstructured nature of the data, says Paul Santos, managing partner at Wavemaker Partners.
  • To speed this up, Wavemaker Partners has invested in Staple, a Singapore-based startup that applies AI to provide document processing solutions.
  • The VC firm has led a US$4 million pre-series A funding round in the startup, which can process various document types across over 200 languages.

Elevarm Raises US$2.6M to Empower Indonesia’s Small-Holder Farmers | E27

By e27

  • Indonesia’s integrated farming productivity platform Elevarm has secured US$2.6 million in a seed funding round led by Singapore’s Insignia Ventures Partners.
  • 500 Global and eFishery founder and CEO Gibran Huzaifa also participated.
  • The strategic raise, completed in two phases, will be used to scale Elevarm’s seedlings and organic fertiliser production capacity threefold to meet growing demand.

Jejakin raises US$2.7M to help organisations achieve net zero targets | e27

By e27

  • Jejakin, an Indonesian-based carbon management platform, has secured US$2.7 million in a funding round from Bhinneka Power, Indogen Capital, SMDV, and East Ventures.
  • The capital will be mainly invested in R&D, technological improvement, and market growth.
  • Jejakin was founded in 2018 by Arfan Arlanda, Sudono Salim (CGO), Andreas Djingga (COO), and Haris Iskandar (Chief of Sustainability and Climate Change) with a mission to make a positive impact on the environment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | US Hols; Aisin to Unwind Exedy Stake and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | US Hols; Aisin to Unwind Exedy Stake
  • #1 India Insights : Tata Motors-JLR Strengthens Tie Ups, Reliance-Airtel Tussle and Macro Insights
  • #5Business Buzz: China’s $47.5B Chip Fund, Ambani’s Africa Telecom Venture, Japan’s Output Rebounds


Ohayo Japan | US Hols; Aisin to Unwind Exedy Stake

By Mark Chadwick

  • US market holiday. Nikkei Futures point to higher open. Oil prices higher as Europe hints at interest rate cuts
  • Aisin (7259) will dissolve its capital alliance with EXEDY, selling its 34.5% stake to fund EV product development and shareholder returns.
  • Mitsubishi Corporation (8058) will sell British food manufacturer Princess to Italy’s Newlat Food for £700 million by July’s end

#1 India Insights : Tata Motors-JLR Strengthens Tie Ups, Reliance-Airtel Tussle and Macro Insights

By Sudarshan Bhandari

  • JLR to produce cars in India but for the first time
  • Reliance – Airtel may tussle on the African Markets after Indian Market
  • FII may show interest to Indian Markets to reap benefits of demographic dividends

#5Business Buzz: China’s $47.5B Chip Fund, Ambani’s Africa Telecom Venture, Japan’s Output Rebounds

By Nimish Maheshwari

  • Musk’s xAI secures $6 billion to rival OpenAI, aiming for AI dominance.
  • India’s booming public sector raises economic concerns amid private sector decline.
  • China launches $47.5 billion fund to bolster domestic chip industry amidst global tensions.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Technical Analysis: Commodity Comeback and more

By | Daily Briefs, Technical Analysis

In today’s briefing:

  • Commodity Comeback


Commodity Comeback

By Douglas Busch

  • S&P 5700 year end target remains intact after MONTHLY breakout. 
  • Copper and silver rally to resume with dollar potentially falling.
  • Semis continue to lead tech and look for software to join.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Morning Views Asia: GMR Hyderabad International Airport and more

By | Credit, Daily Briefs

In today’s briefing:

  • Morning Views Asia: GMR Hyderabad International Airport, Lippo Karawaci


Morning Views Asia: GMR Hyderabad International Airport, Lippo Karawaci

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Alibaba/JD.com:  Thoughts On The Recent Convertible Bond Issuance and more

By | Daily Briefs, ECM

In today’s briefing:

  • Alibaba/JD.com:  Thoughts On The Recent Convertible Bond Issuance
  • Exedy Corporation Placement – Relatively Large One, Although Buyback Should Aid Share Price
  • Barito Renewables Lockup Expiry – US$8bn Lockup Expiry for Largest Indonesian Market Cap Stock
  • Lalatech Compared to Full Truck Alliance, SF Intra-City, and GOGOX in Eleven Easy Charts
  • Telix Pharmaceutical US ADS – Past Deal Record Hasn’t Been Strong, but Fortune Could Be Turning
  • Shift Up IPO – Peer Comparison – Small in Size but Ranks High on Growth and Margins


Alibaba/JD.com:  Thoughts On The Recent Convertible Bond Issuance

By Steve Zhou, CFA

  • Alibaba Group Holding (9988 HK) and JD.com (9618 HK) both announced the issuance of convertible debt last week (Alibaba on May 23 and JD.com on May 21). 
  • Both have mentioned that the reasons for the issuance are the low funding cost (0.25% coupon for JD.com and 0.5% for Alibaba) and to fund their current share repurchase program. 
  • I think the convertible debt structures makes sense and it is beneficial for both companies to buy back as much as possible at the current share price.

Exedy Corporation Placement – Relatively Large One, Although Buyback Should Aid Share Price

By Clarence Chu

  • Aisin (7259 JP) is looking to raise US$290m from selling its entire stake in Exedy Corp (7278 JP).
  • While the selldown doesn’t seem to be particularly well-flagged, this appears to be another cross-shareholder unwind in Japan.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Barito Renewables Lockup Expiry – US$8bn Lockup Expiry for Largest Indonesian Market Cap Stock

By Ethan Aw

  • Barito Renewables Energy (BREN IJ) raised around US$200m in its Indonesian IPO, after pricing at the top end at IDR780/share. Its eight-month lockup will expire on 29th May 2024.
  • Barito Renewables (BR) is Indonesia’s largest geothermal power producer, and the third-largest globally by installed capacity, as per the firm.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

Lalatech Compared to Full Truck Alliance, SF Intra-City, and GOGOX in Eleven Easy Charts

By Daniel Hellberg

  • We compare Lalatech’s scale, P&L, Balance Sheet, and Cash Flow to peers
  • On several measures, Lalatech is comparable to Full Truck Alliance, SF-Intra
  • Small, unprofitable GOGOX not an appropriate comp for Lalatech, in our view

Telix Pharmaceutical US ADS – Past Deal Record Hasn’t Been Strong, but Fortune Could Be Turning

By Clarence Chu

  • Telix Pharmaceuticals (TLX AU) aims to raise at least US$100m in its US ADS listing. The bookrunners on the deal are Jefferies, Morgan Stanley, Truist Securities, and William Blair.
  • TLX is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. 
  • In this note, we talk about the deal dynamics and the listing impact.

Shift Up IPO – Peer Comparison – Small in Size but Ranks High on Growth and Margins

By Sumeet Singh

  • Shift Up (462870 KS) plans to raise up to US$320m in its upcoming South Korean IPO.
  • Shift Up is a South Korean games developer, which as released three games so far for the global markets.
  • In our previous note, we looked at the company’s past performance. In this note, we will undertake a peer comparison.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Baidu Inc.: What Are Their Expansion Plans Of AI Offerings Beyond Ernie? – Major Drivers and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Baidu Inc.: What Are Their Expansion Plans Of AI Offerings Beyond Ernie? – Major Drivers
  • Tech Supply Chain Tracker (28-May-2024): Liquid cooling market to double by 2025, industry shakeout predicted.
  • Qualcomm Leapfrogs Intel & AMD To Power The First Microsoft CoPilot + PCs
  • JD.com Inc.: How Are They Strengthening the Platform Ecosystem & Continuing Their Market Dominance? – Major Drivers
  • Seatrium – Offshore Ahoy!
  • Inox Wind : Block Deal Trade Special Situations and Tactical Trade Strategy
  • iQIYI Inc.: Initiation of Coverage – How Are They Leveraging Generative AI capabilities? – Major Drivers
  • Amuse Inc (4301) – Monday, Feb 26, 2024
  • Take-Two Interactive Software: Increased Relevance of Mobile and Strategic Titles
  • Genel Energy (GENL.L) – Monday, Feb 26, 2024


Baidu Inc.: What Are Their Expansion Plans Of AI Offerings Beyond Ernie? – Major Drivers

By Baptista Research

  • Baidu’s revenue growth for the first quarter exceeded expectations, with a year-over-year increase of 4%, reaching RMB 23.8 billion.
  • Additionally, Baidu’s continued efforts in Gen AI path have resulted in a 12% year-over-year acceleration in the revenue growth from Baidu AI Cloud, which also delivered an operating profit on a non-GAAP basis.
  • These positive results signify the company’s successful transition from an internet-centric business to an AI-first business.

Tech Supply Chain Tracker (28-May-2024): Liquid cooling market to double by 2025, industry shakeout predicted.

By Tech Supply Chain Tracker

  • Liquid cooling market expected to double by 2025, but industry shakeout predicted by Auras chair.
  • Apple plans to ship over 9 million units of OLED iPad Pro, aiming to boost its market presence.
  • South Korea aims to enhance its IC design sector, currently holding just a 1% share of the global market.

Qualcomm Leapfrogs Intel & AMD To Power The First Microsoft CoPilot + PCs

By William Keating

  • Microsoft last week launched their CoPilot+ PC category which enables their CoPilot to run locally on your PC, as long as it has an NPU with >40 TOPS
  • With Qualcomm being the only one currently offering such an NPU, their Snapdragon processors will be powering the first wave of CoPilot+ PC’s
  • It’s an extraordinary accomplishment for Qualcomm & likely an inflection point for Arm powered PCs. It’s also really bad news for Intel and not great for AMD

JD.com Inc.: How Are They Strengthening the Platform Ecosystem & Continuing Their Market Dominance? – Major Drivers

By Baptista Research

  • JD.com, a China-based multinational technology conglomerate, has announced its first-quarter results for 2024 in an earnings call and reported robust profit and revenue growth, along with an encouragingly high Net Promoter Score (NPS).
  • The revenue growth was accelerated by strong execution amidst evolving industry dynamics, improved user experience, price competitiveness, and platform ecosystems.
  • Importantly, the general merchandise and supermarket category recorded a notable jump in terms of gross merchandise value (GMV) and revenue growth.

Seatrium – Offshore Ahoy!

By Rikki Malik

  • An overlooked old economy sector in Asia ripe for a comeback
  • Industry dynamics will provide  a long-term tailwind for the company
  • Opportunity created by  deletion from an index and corporate restructuring

Inox Wind : Block Deal Trade Special Situations and Tactical Trade Strategy

By Sudarshan Bhandari

  • Impending block deals which generally create supply over-hang on the stock leads to a negative impact on the stock
  • These block deals generally include selling promoters and big funds at a price discount to its current market price
  • Historically, such events suggest once the block deal is done; stock reacts positively creating a Special Situation Opportunity

iQIYI Inc.: Initiation of Coverage – How Are They Leveraging Generative AI capabilities? – Major Drivers

By Baptista Research

  • iQIYI, an innovative market-leading online entertainment service provider in China, delivered robust first-quarter 2024 results, achieving numerous record highs, such as non-GAAP operating income and its corresponding margin.
  • CEO, Mr. Yu Gong, shared that the expanding margin could be attributed to the high-quality growth of the company.
  • The Membership Services business continued its growth trajectory with monthly ARM observed an all-time high.

Amuse Inc (4301) – Monday, Feb 26, 2024

By Value Investors Club

  • The music industry in the west focuses on speculative assets and bundling services, while in Japan firms have 360-degree deals with artists.
  • Amuse, a major player in the Japanese music industry, historically managed the successful band Southern All Stars but has diversified beyond them.
  • Despite still having concentration in top acts like Masaharu Fukuyama, Amuse’s business model and intrinsic value are seen as attractive to investors.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Take-Two Interactive Software: Increased Relevance of Mobile and Strategic Titles

By Baptista Research

  • Take-Two Interactive Software Inc reported a healthy performance for the fiscal fourth quarter of 2024 with net bookings of $1.35 billion.
  • The fiscal year 2024 saw net bookings of $5.33 billion.
  • The performance for the period was attributed to the success of NBA 2K24, Zynga’s in-app purchases, Match Factory!, the Red Dead Redemption series, and the Grand Theft Auto series.

Genel Energy (GENL.L) – Monday, Feb 26, 2024

By Value Investors Club

  • Genel Energy is a high-risk arbitration opportunity with potential for significant reward due to its legal dispute with the Kurdistan government
  • Despite previous market capitalization reduction in the 2014 oil crisis, Genel Energy is now an undervalued asset with strong cash position and minimal debt
  • With current market cap at £210 million and significant cash reserves, the company has notable potential for growth, but the unpredictable nature of the situation makes it difficult to model or quantify with certainty

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars